Form 4: P&G Health Care CEO Sells Shares for Tax Obligation

Jennifer L. Davis, CEO of Health Care at Procter & Gamble, sold 3,227 shares of common stock to cover tax obligations related to a restricted stock unit award.

Summary

• Jennifer L. Davis, CEO Health Care at Procter & Gamble Co (PG), reported a transaction involving the company's common stock.
• On October 2, 2025, Davis disposed of 3,227 shares of common stock at a price of $152.2317 per share.
• The sale was conducted to cover tax obligations arising from the settlement of a Restricted Stock Unit Award.
• Following the transaction, Davis directly beneficially owns 61,763.9326 shares of common stock.
• Additionally, Davis indirectly beneficially owns 15,535.3029 shares of common stock through a retirement plan trustee.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (sale to cover taxes on RSU settlement) which is neutral in sentiment and does not indicate any significant positive or negative developments for the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This transaction represents a routine insider filing, common for executives who receive equity compensation. Sales to cover tax obligations upon the vesting or settlement of restricted stock units are a standard practice and typically do not reflect a change in management's outlook on the company's prospects.

Comparison to Industry Standards

• The sale of shares to cover tax obligations upon the vesting of restricted stock units is a common and expected practice among executives across various industries, including consumer staples.
• This type of transaction is generally pre-planned, often under a Rule 10b5-1 trading plan, to manage tax liabilities associated with equity compensation.
• The reported transaction amount is not unusually large for an executive at a company of Procter & Gamble's size, suggesting it is a standard part of compensation management rather than a significant change in investment strategy.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, tax-related sale by an executive and does not signal a change in company fundamentals or executive confidence.
• Employees: No direct impact mentioned or implied by this filing.
• Customers/Suppliers/Creditors: No direct impact mentioned or implied by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine, tax-related sale of shares by an executive upon the settlement of restricted stock units. Such transactions are common and typically pre-planned, not indicative of a change in the company's fundamental outlook or the executive's confidence. Therefore, it does not provide new information that would warrant a change in investment recommendation; a 'hold' stance remains appropriate based solely on this filing.

Keywords

Procter & Gamble, PG, Insider Transaction, Form 4, Stock Sale, Executive Compensation, Jennifer L. Davis, Restricted Stock Units